Answers are grounded in this paper and cite their sources.
Magnesium alloys are attractive biodegradable biomaterials, but their high corrosion rate in physiological fluids limits their clinical use. Polymeric coatings with tailored architecture offer a route to control degradation more precisely than commercial biopolymers. Herein, a grafted copolymer of poly(2-hydroxyethyl methacrylate) and polycaprolactone (PHEMA-g-PCL) via a one-pot combination of reversible addition-fragmentation chain-transfer (RAFT) polymerization and ring-opening polymerization (ROP), yielded a copolymer with Mn of 63.9 kg∙mol−1 and Mw/Mn ratio of 1.21, confirmed by Size Exclusion Chromatography (SEC). The chemical structure of the copolymer was confirmed by Nuclear Magnetic Resonance (NMR) and Fourier Transformation Infrared (FTIR) spectroscopy. The alloy substrate, a hot-rolled Mg-Y-Gd-Zr alloy, was dip-coated using 5 wt.% and 10 wt.% PHEMA-g-PCL solutions, and corrosion behavior was evaluated by hydrogen evolution and pH monitoring during immersion in Hank’s solution at 37 °C. Uncoated samples corroded fastest ((0.0145 ± 0.0009) mL·mm−2·h−1) and perforated within 3 days, whereas the 10 wt.% PHEMA-g-PCL coating, which formed a continuous film, reduced the corrosion rate to ((0.0045 ± 0.0002) mL·mm−2·h−1) and preserved structural integrity for over 170 h. The 5 wt.% coating only partially covered the substrate, resulting in more variable corrosion behavior, (0.0068 ± 0.0029) mL·mm−2·h−1. These results establish PHEMA-g-PCL as a proof-of-concept coating strategy for tuning Mg alloy degradation.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: